Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial

BACKGROUND: The effect of enzalutamide on health-related quality of life (HRQoL) in the PREVAIL trial in chemotherapy-naïve men with metastatic castration-resistant prostate cancer was analyzed using the generic EQ-5D instrument. METHODS: Patients received oral enzalutamide 160 mg/day (n = 872) or p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Qual Life Outcomes
Main Authors: Devlin, Nancy, Herdman, Michael, Pavesi, Marco, Phung, De, Naidoo, Shevani, Beer, Tomasz M., Tombal, Bertrand, Loriot, Yohann, Ivanescu, Cristina, Parli, Teresa, Balk, Mark, Holmstrom, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5481866/
https://ncbi.nlm.nih.gov/pubmed/28645287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-017-0704-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados